A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
NCT05918692
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
BMF-500
Sponsor
Biomea Fusion Inc.